Answers are grounded in this paper and cite their sources.
Immune evasion by escape mutations subverts immunity against SARS‐CoV‐2. A role of pan‐coronavirus immunity for more durable protection is being discussed, but has remained understudied. We here investigated the effects of age, mutations, and homo‐/heterologous vaccination regimens on the dominant pan‐coronavirus‐specific cellular and humoral epitope iCope after SARS‐CoV‐2 infection and vaccination in detail. In older individuals, the quantitatively and qualitatively reduced iCope‐reactive CD4 + T cell responses with narrow TCR repertoires could not be enhanced by vaccination and were further compromised by emerging spike mutations. In contrast, pan‐coronavirus‐reactive humoral immunity was affected only by mutations and not by age. Our results reveal a distinct deficiency of the dichotomous layer of pan‐coronavirus immunity in the older, critical for long‐term protection against SARS‐CoV‐2 variants.
No takes yet. Share an insight, caveat, or question.
Loyal et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: